Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01434355 : DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or Siblings
AgesMin: N/A Max: 19 Years
Inclusion Criteria:

- The patient is enrolled on COG-ACCRN07

- The patient has a primary diagnosis of germ cell tumor (GCT) including germinoma
(ICCC 9060-9065) teratoma (9080-9084), embryonal carcinoma (9070-9072), yolk sac
tumor (9071),choriocarcinoma (9100, 9103, 9104), and mixed GCT (9085, 9101, 9102,
9105) in all sites including the brain and central nervous system and registered with
Children's Oncology Group (COG) by a North American member institution

- The patient must be diagnosed with a germ cell tumor between July 1, 2008 and
December 31, 2015

- The patient must be < 20 years of age at the time of diagnosis

- The patient must have at least one biological parent alive and willing to participate

- In the event that one case parent cannot contribute DNA, a case sibling, defined
as the biological brother or sister of the study subject, may donate instead

- All questionnaire respondents must understand English or Spanish

- Concomitant treatment on a therapeutic trial is not required
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557